Solid lipid nanoparticles as a drug delivery system for peptides and proteins.

By A. Almeida, E. Souto. Advanced Drug Delivery Reviews, 2007

803 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Advanced Materials and Processing for Drug Delivery: The Past and the Future (2012, background): “to $121 billion in 2010 [3]; the annual worldwide market for polymer-based controlled release system alone is estimated to be $60 billion in 2010 [4].”
Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages (2018, neutral): “Almeida 2007 (85) Peptides and proteins”
Biocompatibility of engineered nanoparticles for drug delivery. (2013, methodology): “SLNs are versatile in their methods of drug incorporation; drugs can be loaded into the particle's core or shell, between lipid layers and fatty acid chains, in the particle's imperfections, or dispersed molecularly throughout the particle's matrix [173].”